Maddie Graham Patient Family

This will be Maddie’s first event with the MMRF. She is looking forward to a week of cycling in honor of her dad who passed away from multiple myeloma in March of 2020. She and her dad went on many adventures together, even after his diagnosis, and he was always her biggest fan. Maddie competed on her collegiate cycling team, and though she doesn’t ride as much as she did during that season, she’s excited to be out on the road again and pushing herself in honor of her dad, who was the strongest person she ever knew. She’s thankful for opportunities to support ongoing research and provide other patients and their families with hope or a better future and more years together.

https://give.themmrf.org/InMemory-TyGraham

Sorry, there are no posts from this member.
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More